2nd Annual Oligonucleotides for CNS Summit
Evvnt Promotion / evvnt
13.06.2022 - 15.06.2022 Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 7:00 AM - 3:15 PM
Temi della conferenza
With Biogen investing millions in Ionis' efforts to weaponize ASOs against SMA, Stoke Therapeutics collaborating with Acadia Pharmaceuticals to supercharge the development of RNA-Based treatments for genetic neurodevelopmental diseases and the global oligonucleotide therapeutics market set to experience unprecedented growth, there’s never been a more opportune moment for biopharma to expand their oligonucleotide pipelines into the untapped potential of the CNS.
With Biogen investing millions in Ionis' efforts to weaponize ASOs against SMA, Stoke Therapeutics collaborating with Acadia Pharmaceuticals to supercharge the development of RNA-Based treatments for genetic neurodevelopmental diseases and the global oligonucleotide therapeutics market set to experience unprecedented growth, there’s never been a more opportune moment for biopharma to expand their oligonucleotide pipelines into the untapped potential of the CNS.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Informazioni ed Iscrizioni:
https://go.evvnt.com/1054624-2?pid=4832
Ms. Stephanie Nketia
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
